{"favorite_id": 3942, "full_title_en": "Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Decision Aid", "short_title_en": "T-MACS", "medium_description_en": "Rules out acute coronary syndrome.", "short_description_en": "Rules out ACS.", "specialty_en": ["Cardiology", "Emergency Medicine"], "system_en": ["Cardiac"], "disease_en": ["Acute Coronary Syndrome"], "chief_complaint_en": ["Abdominal Pain", "Anxious", "Chest Pain", "Dizziness", "Dyspnea"], "purpose_en": ["Diagnosis", "Rule Out"], "search_abbreviation_en": ["ACS", "MACS", "TMACS", "T MACS", "T-MACS", "troponin", "trop", "heart attack", "MI", "myocardial infarction", "angina", "crescendo angina", "ecg", "ekg"], "seo": {"meta_description_en": "The Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Decision Aid rules out acute coronary syndrome.", "keywords_en": "ACS, MACS, TMACS, T MACS, T-MACS, troponin, trop, heart attack, MI, myocardial infarction, angina, crescendo angina"}, "content": {"how_to_use": {"use_case_en": "<p>Patients with chest pain that may be cardiac in nature.</p>", "pearls_pitfalls_en": "<ul> <li>The T-MACS Decision Aid predicts acute coronary syndrome (ACS) or 30-day major adverse cardiac events (MACE) in patients with suspected cardiac chest pain.</li> <li>30-day MACE was defined as acute myocardial infarction (AMI), death, or coronary revascularization.</li> <li>Uses high sensitivity cardiac troponin T (hs-cTnT), along with subjective symptoms and objective signs to risk stratify chest pain patients with suspected cardiac chest pain.</li> <li>Uses a single hs-cTnT measurement on arrival, not serial values like other chest pain scores.</li> <li>Inclusion and exclusion criteria differed slightly between the derivation and validation sets, e.g. chest pain within 12 vs. 24 hours of onset; age limits 16 vs. 18 vs. 25 years old.</li> </ul> <p><strong>Point to Keep in Mind:</strong></p> <ul> <li>Remember, hs-cTNT is also a <em>low-specificity</em> troponin. While it may suggest ACS in high-risk patients, it can be elevated for many other reasons besides acute coronary syndromes. See Evidence for differential diagnoses.</li> </ul>", "why_use_en": "<ul> <li><span>Can essentially rule </span><strong>OUT</strong><span> ACS in very low risk patients. </span></li> <li><span>Can essentially rule </span><strong>IN</strong><span> ACS in high risk patients. </span></li> <li><span>Can avoid costly hospital admissions or risk of harm from invasive tests in patients predicted not to have ACS or risk of 30-day MACE.</span></li> </ul>"}, "next_steps": {"advice_en": "", "management_en": "", "critical_actions_en": "<ul> <li>T-MACS is a decision aid and not a definitive test. It is designed to assist in the workup of a patient\u2019s chest pain. Clinical judgment should always be used.</li> <li>If all the components of the T-MACS decision aid are negative, ACS can essentially be ruled out without having to calculate the score.</li> </ul>"}, "about": {"formula_en": "<p>Probability of ACS (p)&nbsp;=&nbsp;</p> <img src=\"https://cdn-web-img.mdcalc.com/content/t-macs.png\"> <p>where:</p> <table> <tbody> <tr> <td>&nbsp;</td> <td> <p><strong>No</strong></p> </td> <td> <p><strong>Yes</strong></p> </td> </tr> <tr> <td> <p><strong>E: EKG ischemia</strong></p> </td> <td> <p>0</p> </td> <td> <p>1</p> </td> </tr> <tr> <td> <p><strong>A: Worsening or crescendo angina</strong></p> </td> <td> <p>0</p> </td> <td> <p>1</p> </td> </tr> <tr> <td> <p><strong>R: Pain radiation to the right arm or shoulder</strong></p> </td> <td> <p>0</p> </td> <td> <p>1</p> </td> </tr> <tr> <td> <p><strong>V: Pain associated with vomiting</strong></p> </td> <td> <p>0</p> </td> <td> <p>1</p> </td> </tr> <tr> <td> <p><strong>S: Sweating observed</strong></p> </td> <td> <p>0</p> </td> <td> <p>1</p> </td> </tr> <tr> <td> <p><strong>H: Hypotension</strong></p> </td> <td> <p>0</p> </td> <td> <p>1</p> </td> </tr> <tr> <td> <p><strong>T: hs-cTnT concentration on arrival</strong></p> </td> <td colspan=\"2\"> <p>hs-cTnT value&nbsp;</p> </td> </tr> </tbody> </table> <p><span><br>Remember, hs-cTnT has low specificity\u2014troponin may be elevated by a number of non-ACS etiologies, including:</span></p> <table> <tbody> <tr> <td colspan=\"3\"> <p align=\"center\"><strong>Cardiac causes</strong></p> </td> </tr> <tr> <td> <p><span>Cardiac contusion (trauma)</span></p> </td> <td> <p><span>Heart failure, acute and chronic</span></p> </td> <td> <p><span>Tachy- or bradyarrhythmia, heart block</span></p> </td> </tr> <tr> <td> <p><span>Cardiac surgery</span></p> </td> <td> <p><span>Aortic dissection</span></p> </td> <td> <p><span>Apical ballooning syndrome</span></p> </td> </tr> <tr> <td> <p><span>Cardioversion</span></p> </td> <td> <p><span>Aortic valve disease</span></p> </td> <td> <p><span>Post-PCI</span></p> </td> </tr> <tr> <td> <p><span>Endomyocardial biopsy</span></p> </td> <td> <p><span>Hypertrophic cardiomyopathy</span></p> </td> <td> <p><span>Rhabdomyolysis with myocyte necrosis</span></p> </td> </tr> <tr> <td> <p><span>Myocarditis</span></p> </td> <td> <p><span>Endocarditis</span></p> </td> <td> <p><span>Pericarditis</span></p> </td> </tr> <tr> <td colspan=\"3\"> <p align=\"center\"><strong>Non-cardiac causes</strong></p> </td> </tr> <tr> <td> <p><span>PE</span></p> </td> <td> <p><span>Severe pulmonary HTN</span></p> </td> <td> <p><span>Renal failure</span></p> </td> </tr> <tr> <td> <p><span>Stroke, SAH</span></p> </td> <td> <p><span>Amyloidosis, other infiltrative diseases</span></p> </td> <td> <p><span>Cardiotoxic drugs</span></p> </td> </tr> <tr> <td> <p><span>Critical illness</span></p> </td> <td> <p><span>Sepsis</span></p> </td> <td> <p><span>Extensive burns</span></p> </td> </tr> <tr> <td> <p><span>Extreme exertion</span></p> </td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> </tbody> </table> <p><span>From </span><a href=\"http://circ.ahajournals.org/content/124/21/2350/tab-figures-data#fig-data-figures\" target=\"_blank\"><span>Mahajan 2011</span></a><span>.</span></p>", "more_info_en": "<p>Interpretation:</p> <table> <tbody> <tr> <td> <p><strong>Probability</strong></p> </td> <td> <p><strong>Risk</strong></p> </td> <td> <p><strong>Interpretation</strong></p> </td> </tr> <tr> <td> <p>&lt;0.02</p> </td> <td> <p>Very low</p> </td> <td> <p>ACS ruled out. Consider discharge.</p> </td> </tr> <tr> <td> <p>\u22650.02 and &lt;0.05</p> </td> <td> <p>Low</p> </td> <td> <p>Consider serial troponin in ED ward, e.g. 3h troponin; consider discharge if normal.</p> </td> </tr> <tr> <td> <p>\u22650.05 and &lt;0.95</p> </td> <td> <p>Moderate</p> </td> <td> <p>Serial troponin in general ward and consider stress testing and/or CT coronary angiography thereafter.</p> </td> </tr> <tr> <td> <p>\u22650.95</p> </td> <td> <p>High</p> </td> <td> <p>ACS ruled in. Refer to cardiology, treat for ACS.</p> </td> </tr> </tbody> </table>", "evidence_based_medicine_en": "<p>The original derivation of the T-MACS Decision Aid was a prospective study by <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/27565197\" target=\"_blank\">Body et al</a> in the United Kingdom. The goal was to compare ability of T-MACS to the original MACS, the latter of which included both hs-cTnT and H-FABP (heart-type fatty acid binding protein) in predicting ACS or MACE.</p> <p><strong>Patient Cohorts:</strong></p> <ul> <li>Derived from 703 ED patients from Manchester Royal Infirmary.</li> <li>Validated in set of 3 cohorts: 462 from Stepping Hill Hospital, 191 from Manchester Royal Infirmary, and 806 from Poole NHS Foundation Trust.</li> <li>Included ED patients complaining of chest pain who the clinician suspected as possibly having cardiac chest pain.</li> <li>Caveat: Unlike patients in the other 2 validation cohorts, patients from Poole that had EKG findings of ischemia were excluded from the study.</li> </ul> <p><strong>Follow-up: </strong></p> <p>Standard troponin test &gt;12 hours after peak symptoms or least 6 hours after ED presentation. Patients (or their primary care physician) were also contacted after 30 days.</p> <p><strong>Outcomes: </strong></p> <p>The primary outcome was diagnosis of ACS or MACE (AMI, death, coronary revascularization) in 30 days, with a secondary outcome of &gt;50% coronary stenosis, even if no intervention was undertaken.</p> <p><strong>Results in the derivation set:</strong></p> <ul> <li>22.3% had ACS (18.5% with AMI).</li> <li>37.7% were labeled as very low risk for ACS (<abbr title=\"Negative Predictive Value\">NPV</abbr> 99.3%).</li> <li>Two patients labeled as very low risk had ACS.</li> <ul> <li>#1: hs-cTnT of 9 ng/L and non-ischemic EKG within 1 hour of symptom onset but cTnT of 2650 ng/L at 12 hours.</li> <li>#2: Percutaneous coronary intervention (PCI) within 30 days despite normal cTnT levels.</li> </ul> <li>10.1% were labeled as high risk for ACS (<abbr title=\"Positive Predictive Value\">PPV</abbr> 100%).</li> </ul> <p><strong>Results in the validation set:</strong></p> <ul> <li>14.5% had ACS (11.8% with AMI).</li> <li>40.4% were labeled as very low risk for ACS (NPV 99.3%).</li> <li>Four patients labeled as very low risk had ACS.</li> <ul> <li>#1: hs-cTnT 6 ng/L on arrival, 43 ng/L at hour 6; &nbsp;paroxysmal supraventricular tachycardia.</li> <li>#2: hs-cTnT 6 ng/L on arrival, 18 ng/L at hour 6; moderate <abbr title=\"Left Anterior Descending\">LAD</abbr> stenosis on CT coronary angiography but no intervention.</li> <li>#3: Ischemic chest pain, PCI on day 4.</li> <li>#4: Ischemic chest pain, PCI on day 8.</li> </ul> <li>Seven patients (1.2%) labeled as very low risk had stenosis found on angiography but did not have intervention.</li> <li>4.7% were labeled as high risk for ACS (PPV 84%).</li> </ul> <p><strong>Comparing T-MACS to MACS:</strong></p> <ul> <li>Compared to its predecessor, MACS (which incorporated both hs-cTnT and H-FABP), T-MACS uses a lower hs-cTnT threshold without greatly sacrificing sensitivity.</li> <li>MACS with 18.0% labeled as very low risk vs. T-MACS 40.5%.</li> <li>Sensitivity for MACS was 100% vs. T-MACS 98.4% (<em>p</em>=0.25).</li> </ul> <p><strong>Conclusion:</strong></p> <ul> <li>~40% can be labeled as very low risk with &lt;1% probability of ACS.</li> <li>~5% can be labeled as high risk of ACS.</li> </ul>", "references_list": {"Original/Primary Reference": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/27565197 ", "text": "Body R, Carlton E, Sperrin M, et al. Troponin-only Manchester Acute Coronary Syndromes (T-MACS) decision aid: single biomarker re-derivation and external validation in three cohorts. Emerg Med J. 2016; Epub ahead of print."}], "Validation": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/27565197", "text": "Body R, Carlton E, Sperrin M, et al. Troponin-only Manchester Acute Coronary Syndromes (T-MACS) decision aid: single biomarker re-derivation and external validation in three cohorts. Emerg Med J. 2016; Epub ahead of print."}, {"href": "http://emj.bmj.com/content/early/2017/03/30/emermed-2016-206366", "text": "Greenslade JH, Nayer R, Parsonage W, et al. Validating the Manchester Acute Coronary Syndromes (MACS) and Troponin-only Manchester Acute Coronary Syndromes (T-MACS) rules for the prediction of acute myocardial infarction in patients presenting to the emergency department with chest pain. Emerg Med J. 2017;"}]}}, "contributor": {"expert_name": [{"description": "<p>Hyunjoo Lee, MD, is a clinical assistant professor in emergency medicine at Stony Brook University Hospital. Born and raised in New York, she left New York for her undergraduate studies at Swarthmore College where she received a BA in Biology. She returned to New York and did research in B-cell biology and CLL before heading back to school to obtain her MD from Stony Brook University School of Medicine. She completed her emergency medicine residency at Mount Sinai Beth Israel in New York City and a medical education fellowship in the department of emergency medicine at Thomas Jefferson University in Philadelphia.</p>", "firstName": "Hyunjoo", "img": "https://cdn-web-img.mdcalc.com/people/hyunjoo-lee.jpg", "lastName": "Lee", "name": "Hyunjoo Lee, MD", "target": "hyunjoo-lee", "signedCOI": true, "hasDisclosure": []}]}, "creator": [{"name": "Dr. Richard Body", "qa_en": "", "creator_info": {"about_en": "<p>Richard Body, MB ChB, MRCSEd (A&E), FRCEM, PhD, is an emergency medicine professor and honorary consultant in emergency medicine at the University of Manchester in the UK. He is also the founder of the Manchester Acute Coronary Syndromes (MACS) Academic Group and the Manchester Emergency Medicine and Intensive Care Research Group (EMERGING). Dr. Body\u2019s primary research is focused on early diagnosis of acute coronary syndromes.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-rick-body.jpg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Body+R%5BAuthor%5D"}}]}, "instructions_en": "", "input_schema": [{"label_en": "EKG ischemia", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "default": 0, "show_points": true, "tips_en": "As determined by treating clinician", "type": "toggle", "name": "ecg", "optional": false}, {"label_en": "Worsening or crescendo angina", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "default": 0, "show_points": true, "type": "toggle", "name": "ang", "optional": false}, {"label_en": "Pain radiating to right arm or shoulder", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "default": 0, "show_points": true, "type": "toggle", "name": "pnrad", "optional": false}, {"label_en": "Pain associated with vomiting", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "default": 0, "show_points": true, "type": "toggle", "name": "vomit", "optional": false}, {"label_en": "Sweating observed", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "default": 0, "show_points": true, "tips_en": "As observed by treating clinician", "type": "toggle", "name": "sweat", "optional": false}, {"label_en": "Hypotension", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "default": 0, "show_points": true, "tips_en": "<abbr title='Systolic blood pressure'>sBP</abbr> <100 mmHg on arrival to ED", "type": "toggle", "name": "hypo", "optional": false}, {"label_en": "<abbr title='High sensitivity cardiac troponin T'>hs-cTnT</abbr> concentration on arrival", "unit": "hsctnt", "type": "textbox", "name": "tnt", "optional": false, "unit_info": {"name": "hs-cTnT", "conversion": 1000, "error_min": 0, "error_max": 10, "warn_min": 0, "warn_max": 10, "normal_max_si": 14, "normal_min_si": 0, "normal_min_us": 0, "units_si": "ng/L", "units_us": "\u00b5g/L", "normal_max_us": 0.014}}], "slug": "troponin-manchester-acute-coronary-syndromes-t-macs-decision-aid", "calc_type": "calculator", "dosing": false, "before_use": "", "md5": "e816f6c9bbc17664c01361babdf45945", "cmeVersion": "3942.1", "related_calcs": [{"calcId": 111, "short_title_en": "TIMI Score for UA/NSTEMI", "slug": "timi-risk-score-ua-nstemi"}, {"calcId": 10067, "short_title_en": "CCS Angina Grade", "slug": "canadian-cardiovascular-society-ccs-angina-grade"}, {"calcId": 665, "short_title_en": "TIMI Risk Index", "slug": "timi-risk-index"}]}